Global Animal Vaccines Market by Animal Type (Companion, Ruminants, Poultry, Aqua) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Global animal vaccines market was valued at USD 9.2 Billion in 2020. It is projected to grow at a compound annual rate (CAGR of 7.4%) between 2021 and 2028. Market dynamics have changed due to the constant introduction of new vaccines and the spread of diseases in livestock. Market dynamics have changed from living attenuated vaccines to DNA vaccinations. Recombinant vaccines are quickly being adopted.
The market for animal vaccines will continue to be innovative, and there will be frequent acquisitions and strategic alliances. Competitive advantage will depend on product development and competent distribution channels. Market growth will be driven by the increasing demand for animal-derived foods products and regulatory mandates.
All industries were affected by the COVID-19 pandemic, even animal vaccines. OIE currently confirms that this virus cannot be spread from animals. However, there have been cases of human-to-animal transmission in some countries. IDEXX Laboratories has tested a lot of dogs and cats for the virus. Test results have been negative. There was speculation that the virus could spread to birds during the initial months of this pandemic. This negatively affected the livestock industry. After the outbreak, many U.S. poultry and pig processing plants were closed. Due to concerns and fears about the novel coronavirus, India's poultry industry has already lost approximately USD 1 billion.
In India, 9 states were affected by the bird flu epidemic in December 2020. The overall impact on the livestock industry has been severed by the drop in the prices of poultry products. According to the Poultry Federation of India (PFI), chicken consumption has dropped to 50% and prices have fallen by 30% as of December 2020. India is the only country that has not adopted vaccine policies in Asia. The Haryana and Punjab state governments are close in legalizing vaccinations. This could have a positive impact on the market.
Human lives can be negatively affected by zoonotic disease, which will likely increase the demand for animal vaccines. The CDC released a list of the top 8 infectious diseases that are easily transmitted from animals to people in May 2019. This was done in partnership with USDA and the U.S. Department of the Interior. These diseases include salmonellosis and West Nile virus. The CDC has taken steps to protect people against zoonotic disease.
Product Insights
Attenuated live vaccinations dominated the market for animal vaccins in 2020 and had a revenue share exceeding 36.0%. Live attenuation, the oldest method of vaccination in the veterinary world, is still being used. The development of new applications is currently underway for this method. One of these options is the development of intramuscular protein subunit vaccines. These products help reduce mortality and increase the lifespan of disease-affected swine.
Over the forecast period, the recombinant vaccine market is expected to grow at a lucrative rate. These vaccinations reduce the risk of animal pathogenicity after vaccination. Because recombinant vaccines can be infused with multiple gene inserts, they are expected to aid in vaccination against multiple strains of virus. These vaccine formulations can be made without the use of adjuvants and increase the vaccine's viability and stability. There are a few recombinant vaccines that can be used for veterinarian medicine. These include vaccines against canine distemper and pseudorabies as well as Lyme disease, Lyme disease, Lyme disease, Lyme disease and avian flu.
Information on Animal Types
In 2020, the highest revenue share was held by the ruminants segment of the animal vaccines market. It accounted for over 25% of the total revenue. This dominance can be attributed to factors like rising livestock populations, supportive government initiatives, and the outbreak of diseases in cattle and sheep. Globally, there were approximately 1,200 PPR-related outbreaks in 2019, compared with 3,500 in 2015. This was due to a vaccination campaign by FAO and partners in over 50 countries, which is further propelling market.
The fastest expected growth is in the poultry segment during the forecast period. This segment is driven by a high consumption of poultry products daily. The demand for poultry products will increase by approximately 20% by 2028, according to estimates. High-quality poultry products can be produced using a wide variety of pharmaceuticals, vaccines, and feeds. This expands the potential for growth. Due to growing consumer awareness and high demand for poultry products, the poultry market is a top investment area.
Regional Insights
North America was the dominant market, accounting for 26.6% of the total revenue in 2020. This region will continue to dominate the market for the entire forecast period. The high incidence of livestock diseases and zoonotic disease that can cause large-scale animal death is responsible for the large market share. The market growth is expected to be boosted by the presence of established pharmaceutical companies that are constantly striving to increase their commercialization and geographic reach. The market share is also being boosted by the increasing incidence of canine diseases and the growing pet population in the United States.
The fastest growing market in Asia Pacific is anticipated to be during the forecast period. Market growth will be boosted by the expected increase in livestock population and government initiatives, especially in developing countries. The National Dairy Development Board 2019 estimates that India has 192.5 million cattle. This huge country's cattle population calls for high vaccine demand. High R&D spending by major players and rising attempts to commercialize veterinary vaccines at low prices are the main drivers of this market.
Market Share Insights & Key Companies
This market is highly competitive, and is dominated by a variety of small and large-scale animal vaccine manufacturers. Competition is influenced by rapid adoption of preventive injections for veterinary purposes and government-aided bulk purchases of vaccines.
Major players often choose to diversify their product portfolio and use various strategies in order to maintain share. Ceva, for example, partnered with INRAE in February 2021 for R&D on infectious diseases prevention and animal health . Zoetis introduced the Poulvac Procerta HVT–IBD vaccine to protect poultry from Infectious Bursal Disease (IBD) in January 2021. This was added to the company’s portfolio of recombinant vaccines. Among the most prominent players in animal vaccines are:
-
Merck & Co., Inc.
-
Zoetis
-
Boehringer Ingelheim International GmbH
-
Virbac
-
Biogenesis Bago,
-
Indian Immunologicals Ltd.
-
Elanco
-
Ceva
-
Phibro Animal Health Corporation
-
Neogen Corporation
-
Intas Pharmaceuticals Ltd
-
Ourofino Saude Animal
Up Market Research published a new report titled “Animal Vaccines Market research report which is segmented by Animal Type (Companion, Ruminants, Poultry, Aqua), By Players/Companies Zoetis, Neogen Corporation, Virbac, Biog©nesis Bag³, Ourofino Saºde Animal, Boehringer Ingelheim International GmbH, Phibro Animal Health Corporation, Intas Pharmaceuticals Ltd, Ceva, Indian Immunologicals Ltd, Elanco, Merck & Co Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
Report Attributes | Report Details |
Report Title | Animal Vaccines Market Research Report |
By Animal Type | Companion, Ruminants, Poultry, Aqua |
By Companies | Zoetis, Neogen Corporation, Virbac, Biog©nesis Bag³, Ourofino Saºde Animal, Boehringer Ingelheim International GmbH, Phibro Animal Health Corporation, Intas Pharmaceuticals Ltd, Ceva, Indian Immunologicals Ltd, Elanco, Merck & Co Inc |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 200 |
Number of Tables & Figures | 140 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Animal Vaccines Market Report Segments:
The market is segmented by Animal Type (Companion, Ruminants, Poultry, Aqua).
Animal Vaccines Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Animal Vaccines Market
Overview of the regional outlook of the Animal Vaccines Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Animal Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Animal Vaccines Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Companion
2. Ruminants
3. Poultry
4. Aqua
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Animal Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Animal Vaccines Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Animal Vaccines Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Animal Vaccines Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Animal Vaccines Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Animal Vaccines Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Animal Vaccines Market Size & Forecast, 2018-2028
4.5.1 Animal Vaccines Market Size and Y-o-Y Growth
4.5.2 Animal Vaccines Market Absolute $ Opportunity
Chapter 5 Global Animal Vaccines Market Analysis and Forecast by Animal Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Animal Type
5.1.2 Basis Point Share (BPS) Analysis by Animal Type
5.1.3 Absolute $ Opportunity Assessment by Animal Type
5.2 Animal Vaccines Market Size Forecast by Animal Type
5.2.1 Companion
5.2.2 Ruminants
5.2.3 Poultry
5.2.4 Aqua
5.3 Market Attractiveness Analysis by Animal Type
Chapter 6 Global Animal Vaccines Market Analysis and Forecast by Region
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Region
6.1.2 Basis Point Share (BPS) Analysis by Region
6.1.3 Absolute $ Opportunity Assessment by Region
6.2 Animal Vaccines Market Size Forecast by Region
6.2.1 North America
6.2.2 Europe
6.2.3 Asia Pacific
6.2.4 Latin America
6.2.5 Middle East & Africa (MEA)
6.3 Market Attractiveness Analysis by Region
Chapter 7 Coronavirus Disease (COVID-19) Impact
7.1 Introduction
7.2 Current & Future Impact Analysis
7.3 Economic Impact Analysis
7.4 Government Policies
7.5 Investment Scenario
Chapter 8 North America Animal Vaccines Analysis and Forecast
8.1 Introduction
8.2 North America Animal Vaccines Market Size Forecast by Country
8.2.1 U.S.
8.2.2 Canada
8.3 Basis Point Share (BPS) Analysis by Country
8.4 Absolute $ Opportunity Assessment by Country
8.5 Market Attractiveness Analysis by Country
8.6 North America Animal Vaccines Market Size Forecast by Animal Type
8.6.1 Companion
8.6.2 Ruminants
8.6.3 Poultry
8.6.4 Aqua
8.7 Basis Point Share (BPS) Analysis by Animal Type
8.8 Absolute $ Opportunity Assessment by Animal Type
8.9 Market Attractiveness Analysis by Animal Type
Chapter 9 Europe Animal Vaccines Analysis and Forecast
9.1 Introduction
9.2 Europe Animal Vaccines Market Size Forecast by Country
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 U.K.
9.2.5 Spain
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 Europe Animal Vaccines Market Size Forecast by Animal Type
9.6.1 Companion
9.6.2 Ruminants
9.6.3 Poultry
9.6.4 Aqua
9.7 Basis Point Share (BPS) Analysis by Animal Type
9.8 Absolute $ Opportunity Assessment by Animal Type
9.9 Market Attractiveness Analysis by Animal Type
Chapter 10 Asia Pacific Animal Vaccines Analysis and Forecast
10.1 Introduction
10.2 Asia Pacific Animal Vaccines Market Size Forecast by Country
10.2.1 China
10.2.2 Japan
10.2.3 South Korea
10.2.4 India
10.2.5 Australia
10.2.6 South East Asia (SEA)
10.2.7 Rest of Asia Pacific (APAC)
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Asia Pacific Animal Vaccines Market Size Forecast by Animal Type
10.6.1 Companion
10.6.2 Ruminants
10.6.3 Poultry
10.6.4 Aqua
10.7 Basis Point Share (BPS) Analysis by Animal Type
10.8 Absolute $ Opportunity Assessment by Animal Type
10.9 Market Attractiveness Analysis by Animal Type
Chapter 11 Latin America Animal Vaccines Analysis and Forecast
11.1 Introduction
11.2 Latin America Animal Vaccines Market Size Forecast by Country
11.2.1 Brazil
11.2.2 Mexico
11.2.3 Rest of Latin America (LATAM)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Latin America Animal Vaccines Market Size Forecast by Animal Type
11.6.1 Companion
11.6.2 Ruminants
11.6.3 Poultry
11.6.4 Aqua
11.7 Basis Point Share (BPS) Analysis by Animal Type
11.8 Absolute $ Opportunity Assessment by Animal Type
11.9 Market Attractiveness Analysis by Animal Type
Chapter 12 Middle East & Africa (MEA) Animal Vaccines Analysis and Forecast
12.1 Introduction
12.2 Middle East & Africa (MEA) Animal Vaccines Market Size Forecast by Country
12.2.1 Saudi Arabia
12.2.2 South Africa
12.2.3 UAE
12.2.4 Rest of Middle East & Africa (MEA)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Middle East & Africa (MEA) Animal Vaccines Market Size Forecast by Animal Type
12.6.1 Companion
12.6.2 Ruminants
12.6.3 Poultry
12.6.4 Aqua
12.7 Basis Point Share (BPS) Analysis by Animal Type
12.8 Absolute $ Opportunity Assessment by Animal Type
12.9 Market Attractiveness Analysis by Animal Type
Chapter 13 Competition Landscape
13.1 Animal Vaccines Market: Competitive Dashboard
13.2 Global Animal Vaccines Market: Market Share Analysis, 2019
13.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
13.3.1 Zoetis
13.3.2 Neogen Corporation
13.3.3 Virbac
13.3.4 Biog©nesis Bag³
13.3.5 Ourofino Saºde Animal
13.3.6 Boehringer Ingelheim International GmbH
13.3.7 Phibro Animal Health Corporation
13.3.8 Intas Pharmaceuticals Ltd
13.3.9 Ceva
13.3.10 Indian Immunologicals Ltd
13.3.11 Elanco
13.3.12 Merck & Co Inc